Literature DB >> 11764297

Management of urticaria: a consensus report.

T Zuberbier1, M W Greaves, L Juhlin, H Merk, G Stingl, B M Henz.   

Abstract

This consensus report is the result of a panel discussion during the International Clinically Oriented ESDR Symposium Urticaria 2000. Urticaria has a profound impact on the quality of life and effective treatment is required. The most important are nonsedating H1 antihistamines. They have been proven to be effective in double-blind controlled studies, but concentrations higher than those recommended may be necessary. Due to different urticaria subtypes and the individual variation in the course of the disease and response to treatment, however, alternative therapies may be required. Immunosuppressive drugs like cyclosporine A and corticosteroids should not be used long term due to undesirable side-effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764297     DOI: 10.1046/j.0022-202x.2001.00023.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  6 in total

Review 1.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Chronic urticaria: aetiology, management and current and future treatment options.

Authors:  Martina M A Kozel; Ruth A Sabroe
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Late-phase urticaria Update.

Authors:  Naotomo Kambe; Aki Kitao; Chikako Nishigori; Yoshiki Miyachi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

4.  Management of chronic urticaria in Asia: 2010 AADV consensus guidelines.

Authors:  Steven K W Chow
Journal:  Asia Pac Allergy       Date:  2012-04-30

5.  Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.

Authors:  Mario Sánchez-Borges; Riccardo Asero; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan A Bernstein; G Walter Canonica; Richard Gower; David A Kahn; Allen P Kaplan; Connie Katelaris; Marcus Maurer; Hae Sim Park; Paul Potter; Sarbjit Saini; Paolo Tassinari; Alberto Tedeschi; Young Min Ye; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2012-11       Impact factor: 4.084

6.  Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.

Authors:  Hermenio Lima; Melinda Gooderham; Jan Dutz; Charles Lynde; Hugo Chapdelaine; Anne Ellis; Martin Gilbert; Vincent Ho; Kim Papp; Yves Poulin; Gordon Sussman
Journal:  Allergy Asthma Clin Immunol       Date:  2017-08-24       Impact factor: 3.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.